DuPont opens Industrial Biosciences’ global business headquarters in Delaware
DuPont Industrial Biosciences (IB) has officially opened the doors of its renovated global business headquarters in Wilmington, Del.
DuPont Industrial Biosciences (IB) has officially opened the doors of its renovated global business headquarters in Wilmington, Del. The new center of technological innovation, known as Building E353, is part of DuPont’s Experimental Station—the breeding ground for numerous paradigm-shifting technologies over the decades.
“At this new facility, we have hundreds of people working toward a more sustainable future by innovating biobased solutions that are better, safer, and more renewable. These technologies go into products that are used in everyday life,” said William Feehery, president of DuPont Industrial Biosciences. “The redesigned and upgraded laboratories and office spaces are incubators for some of DuPont’s most groundbreaking work.”
The revitalization of Building E353 is part of a more than $200 million investment in the Experimental Station campus, which began in 2016 and encompasses about 50 buildings, with more than 2 million square feet of space. The E353 refurbishment focused on modernization, consolidation, and advanced capabilities, including:
- Advanced, high-throughput instrumentation, bioinformatics, and genomics capabilities to accelerate discovery and applications research.
- Cutting-edge genome editing capabilities using CRISPR to accelerate microbial production host development.
- Microbiological labs to evaluate tailored animal health solutions and to conduct microbiome science for probiotics product development.
- Highly leveraged fermentation labs to advance “cell factory” end-to-end development and commercialization.
- Leading-edge chemistry and bioprocess science and engineering capabilities to establish high-performance biomaterials platforms.